US20140199777A2 - Graphene oxide filters and methods of use - Google Patents
Graphene oxide filters and methods of use Download PDFInfo
- Publication number
- US20140199777A2 US20140199777A2 US13/940,612 US201313940612A US2014199777A2 US 20140199777 A2 US20140199777 A2 US 20140199777A2 US 201313940612 A US201313940612 A US 201313940612A US 2014199777 A2 US2014199777 A2 US 2014199777A2
- Authority
- US
- United States
- Prior art keywords
- graphene oxide
- fuel
- approximately
- storage vessel
- polar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 90
- 229910021389 graphene Inorganic materials 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 28
- 239000000446 fuel Substances 0.000 claims abstract description 132
- 238000001914 filtration Methods 0.000 claims abstract description 75
- 239000002245 particle Substances 0.000 claims abstract description 57
- 239000012530 fluid Substances 0.000 claims abstract description 38
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000012528 membrane Substances 0.000 claims abstract description 25
- 244000005700 microbiome Species 0.000 claims abstract description 20
- 239000004599 antimicrobial Substances 0.000 claims abstract description 9
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 6
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 5
- 238000003860 storage Methods 0.000 claims description 46
- 238000012856 packing Methods 0.000 claims description 22
- 238000000576 coating method Methods 0.000 claims description 21
- 239000011248 coating agent Substances 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- 239000001301 oxygen Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 239000011521 glass Substances 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 239000000356 contaminant Substances 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 5
- 230000005484 gravity Effects 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000003139 biocide Substances 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 48
- 238000005070 sampling Methods 0.000 abstract description 22
- 239000012535 impurity Substances 0.000 abstract description 13
- 230000007613 environmental effect Effects 0.000 abstract description 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 7
- 239000002798 polar solvent Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 230000000704 physical effect Effects 0.000 abstract description 2
- 238000007306 functionalization reaction Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 66
- 239000010408 film Substances 0.000 description 30
- 239000002609 medium Substances 0.000 description 30
- 230000012010 growth Effects 0.000 description 29
- 108020004414 DNA Proteins 0.000 description 18
- 239000011159 matrix material Substances 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 14
- 230000035755 proliferation Effects 0.000 description 14
- 230000010261 cell growth Effects 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 230000000813 microbial effect Effects 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 12
- 238000011529 RT qPCR Methods 0.000 description 11
- 210000004962 mammalian cell Anatomy 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 239000000123 paper Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 238000004626 scanning electron microscopy Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000011491 glass wool Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 230000000845 anti-microbial effect Effects 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 230000001472 cytotoxic effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002033 PVDF binder Substances 0.000 description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 239000006137 Luria-Bertani broth Substances 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 231100000433 cytotoxic Toxicity 0.000 description 4
- 230000009036 growth inhibition Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000032770 biofilm formation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000003103 bodily secretion Anatomy 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000012414 sterilization procedure Methods 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000002717 carbon nanostructure Substances 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- -1 epoxyl Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003502 gasoline Substances 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 125000001475 halogen functional group Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
- B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
- B01D39/1692—Other shaped material, e.g. perforated or porous sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D24/00—Filters comprising loose filtering material, i.e. filtering material without any binder between the individual particles or fibres thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
- B01D71/021—Carbon
- B01D71/0211—Graphene or derivates thereof
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/281—Treatment of water, waste water, or sewage by sorption using inorganic sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2101/00—Types of filters having loose filtering material
- B01D2101/02—Carbon filters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/04—Additives and treatments of the filtering material
- B01D2239/0407—Additives and treatments of the filtering material comprising particulate additives, e.g. adsorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/04—Additives and treatments of the filtering material
- B01D2239/0442—Antimicrobial, antibacterial, antifungal additives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/04—Additives and treatments of the filtering material
- B01D2239/0471—Surface coating material
- B01D2239/0478—Surface coating material on a layer of the filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Definitions
- the present invention was federally funded, in part, by the Air Force Research Laboratory Fuels and Energy Branch—contract number FA8650-10-2-2934. The government has certain rights in the invention.
- the present invention relates generally to the application of graphene oxide materials to the filtration of fluids.
- Microorganisms are known to colonize and biodeteriorate hydrocarbon fuels. Multiple species of bacteria have been isolated from fuel storage tanks, pipelines, and aircraft wing tanks. Some of the problems associated with microbial growth in aviation fuels include wing and storage tank corrosion, fuel pump failures, filter plugging, injector fouling, topcoat peeling, engine damage, and deterioration of fuel chemical properties and quality. Extensive microbial growth and biofilm formation can lead to costly and disruptive damage to fuel systems and aircraft hardware.
- DiEGME diethylene glycol mono-methyl ether
- GO graphene oxide
- a filter or collection device comprising a fluid inlet, a filtrate outlet, a filtering chamber, and a filter medium.
- the fluid inlet and the filtrate outlet are in fluid communication with the filtering chamber.
- the filter medium which resides in the filtering chamber, comprises polar graphene oxide and has at least one reactive oxygen functional group.
- the polarity of the polar graphene oxide exceeds approximately 0.25 on the E T N scale while comprising an oxygen content exceeding approximately 15%.
- a filter or collection device comprises a polar graphene oxide filter medium characterized by a polarity exceeding approximately 0.25 on the E T N scale and an oxygen content exceeding that of reduced graphene oxide.
- a system for filtering fluids comprising a target fluid fluidly coupled to a target fluid inlet.
- the system comprises a fluid inlet, a filtrate outlet, a filtering chamber, and a filter medium.
- the filter medium which resides in the filtering chamber, comprises polar graphene oxide and has at least one reactive oxygen functional group.
- the polarity of the polar graphene oxide filter medium exceeds approximately 0.25 on the E T N scale while comprising an oxygen content exceeding approximately 15%.
- a method for sampling impurities in an environmental sample utilizing a collection device comprises a fluid inlet, a filtrate outlet, a sampling chamber, and a graphene oxide sampling medium.
- the fluid inlet and the filtrate outlet are in fluid communication with the sampling chamber within which the sampling medium resides.
- the sampling media comprises polar graphene oxide comprising at least one reactive oxygen functional group and is characterized by a polarity exceeding approximately 0.25 on the E T N scale and an oxygen content exceeding approximately 15%.
- the method further comprises exposing the environmental sample to the polar graphene oxide sampling medium such that the polar graphene oxide sampling medium traps impurities residing in the environmental sample.
- FIGS. 1A-C and 2 A-D show possible structures of GO
- FIG. 3 is a schematic view of a system for filtering fluids comprising a filter or collection device
- FIG. 4 is a view of one embodiment of the present disclosure showing a GO coating surrounding a structural core
- FIG. 5 is a view of one embodiment of the present disclosure showing a GO coating on a non-porous structural membrane
- FIG. 6 is a view of one embodiment of the present disclosure showing a GO coating on a filtering membrane
- FIG. 7 is a view of one embodiment of the present disclosure showing a filtering chamber comprising GO particles.
- FIG. 8 is a view of one embodiment of the present disclosure showing a collection device for environmental sampling.
- GO a nanomaterial sheet formed by monolayers of functionalized carbon atoms arranged in thick honeycomb arrays
- the presence of reactive hydroxyl, epoxyl, and carboxyl functional groups on the surface of GO provide physical properties including high solubility in polar solvents, good colloidal properties, low production costs, low toxicity, and a large surface area which can be decorated with antimicrobial agents including nanosilver.
- the degree of surface functionalization imparted to the GO during oxidation determines the solubility of GO in water. Further, while aqueous solutions strongly interact with GO, organic solvents such as jet fuel tend to be repelled by GO.
- GO uses in water, fuel, and solvent microbial purification; single-step kits for rapid extraction and purification of nucleic acids (DNA, RNA), proteins, and cellular metabolites from eukaryotic and prokaryotic cells; surface coatings that inhibit bacteria and virus growth and contamination; encapsulation of high value cell lines and organisms to protect cells and increase product yield.
- DNA nucleic acids
- RNA nucleic acids
- GO may serve as a coating for conventional tissue culture matrices, as culture media additives, and as free-standing film matrices or porous gel-like structures for cell and tissue growth.
- GO has also shown promise in the biomedical field as it promotes the attachment of drugs and antimicrobial agents and enhances the encapsulation of cells.
- GO-based filters may be used for the efficient removal (sterilization) of microorganisms from organic and aqueous liquids; high volume rate filtration due to low pressure buildup (backpressure); and the removal of small quantities of free water from fuels and organic solvents.
- backpressure low pressure buildup
- microorganisms must be removed from fuel before it is stored in tanks and aircrafts. With the development of new biofuels that are more environmentally friendly, but that have a greater potential for biodegradation, new methods to prevent fuel biodeterioration is needed.
- GO filters for the purification and sterilization of fuels are disclosed.
- GO can be used as a filtration media for efficient removal of bacteria from hydrocarbon fuels.
- GO-based filters remove bacteria from fuel with an efficiency ⁇ 99.9%. Additionally, these filters remove small amounts of water from fuels further demonstrating the applicability of GO filters to serve as a last stage water removal system in fuel storage applications; free water present in fuel can lead to engine malfunction due to freezing and increased microbial growth.
- the GO filters allowed rapid flow of fuel with low resistance.
- GO sheets comprise monolayers of carbon atoms that form dense honeycomb structures with unique characteristics.
- GO contains a range of reactive oxygen functional groups that facilitate the application of GO in bioengineering.
- the solubility of GO in solvents, especially water, is important for applications in bioengineering.
- the maximum solubility of GO in a solvent depends both on the solvent polarity and the extent of surface functionalization imparted during oxidation.
- the surface of GO when made from the Hummer's method, has oxygen functional groups, such as hydroxyl, epoxyl and carboxyl, which enable GO to be readily dispersed in water.
- FIG. 3 an embodiment of the present disclosure including a system for filtering fluids comprising a target fluid 30 , flowing in direction A, and a filter or collection device 20 comprising a fluid inlet 1 , a filtrate outlet 2 , a filtering chamber 3 , and a filter medium 4 is shown.
- the target fluid 30 is fluidly coupled to the fluid inlet 1 and the fluid inlet 1 and the filtrate outlet 2 are in fluid communication with the filtering chamber 3 .
- the filter medium 4 which resides in the filtering chamber 3 , is made up of polar GO which may be flakes, a film, a powder, a solution, a suspension, or a GO coated substrate.
- the GO has a polarity exceeding approximately 0.25 on the E T N scale. In other embodiments of the present disclosure, the GO has a polarity exceeding approximately 0.5 on the E T N scale or a polarity exceeding approximately 0.65 on the E T N scale.
- the target fluid 30 may contain DNA, RNA, microorganisms or cells which may be selected from microbes, bacteria, fungi, yeast, algae, or combinations thereof.
- the target fluid 30 may be a non-polar fluid or an organic solvent.
- the organic solvent may comprise hydrocarbons, a hydrocarbon mixture, water, a hydrocarbon-water mixture, or combinations thereof or may be a combustible fuel such as kerosene, jet fuel, gasoline, diesel, or combinations thereof.
- the filter medium 4 may comprise a biocide or antimicrobial agent which, in some embodiments, is silver nanoparticles.
- the GO has been functionalized so that the GO includes at least one reactive oxygen functional group and has an oxygen content exceeding approximately 15%.
- the reactive oxygen functional group may be an ether, hydroxyl, epoxide, ketone, carbonyl, or carboxyl group, or combinations thereof.
- oxygen content represents the atomic percent of oxygen atoms present in the polar GO filter medium 4 as approximately 66% carbon to approximately 33% oxygen corresponding to an atomic ratio of carbon to oxygen of approximately 2:1.
- the oxygen content of the polar GO may be between approximately 30% and approximately 33% or may be approximately 33%. In any event, the oxygen content and the polarity of the polar GO exceed that of reduced GO.
- the filter or collection device 20 is configured as a column filter.
- the filtering chamber 3 may be a fuel storage vessel with the filter medium 4 residing on interior walls of the fuel storage vessel filtering chamber 3 .
- the filter medium 4 may be made up of a plurality of distinct bulk GO filter particles 12 that are packed into a filtering unit 5 within the filtering chamber 3 .
- the GO filter particles 12 may have a maximum cross-sectional dimension may be at least approximately 5 millimeters.
- the plurality of distinct bulk GO filter particles 12 are packed into the filtering unit 5 at a filter particle packing density that permits gravity-induced fluid flow in the direction of Arrow A from the fluid inlet 1 to the filtrate outlet 2 , through the packed GO filter particles 12 of the filter medium 4 in the filtering chamber 3 .
- the GO filter particles 12 are packed into the filtering unit at a filter particle packing density between approximately 0.01 g/cm 3 and approximately 1 g/cm 3 or more preferably at a filter particle packing density between approximately 0.1 g/cm 3 and approximately 0.5 g/cm 3 .
- the plurality of distinct bulk GO filter particles 12 comprise a maximum cross-sectional dimension between approximately 100 micrometers and approximately 5 millimeters and are packed into the filtering unit at a filter particle packing density between approximately 0.01 g/cm 3 and approximately 1 g/cm 3 .
- the plurality of distinct bulk GO filter particles 12 comprise a maximum cross-sectional dimension between approximately 100 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.1 g/cm 3 and approximately 1 g/cm 3 .
- the structural core 6 is non-graphitic and may be of any shape. It will be understood that while the structural core 6 is depicted as a sphere, the structural core 6 may be any regular or irregular shape.
- the structural core 6 may be a bead of glass, polymer, metal, ceramic, carbon, or combinations thereof and may be inert.
- the layer of polar GO 7 surrounding the structural core 6 is made up of a plurality of distinct GO filter particles 12 and is at least approximately 1 micrometer in thickness and may be between approximately 1 micrometer and approximately 1 millimeter in thickness. In another embodiment of the present disclosure, the layer of polar GO 7 is between approximately 1 micrometer and approximately 50 micrometers.
- the GO filter particles 12 comprise a maximum cross-sectional dimension of between approximately 200 micrometers and approximately 4 millimeters. In another embodiment of the present disclosure, it is contemplated that the GO filter particles 12 comprise a maximum cross-sectional dimension of at least approximately 200 micrometers and approximately 1 millimeter.
- a plurality of structural cores 6 surrounded by a layer of GO 7 are packed into the filtering unit 5 .
- the packed plurality of GO coated structural cores 6 together make up the filter medium 4 of the device 20 .
- the plurality of structural cores 6 surrounded by a layer of GO 7 are packed at a filter particle packing density selected to permit gravity-induced fluid flow from the fluid inlet 1 to the filtrate outlet 2 , through the packed GO filter medium 4 in the filtering chamber 3 .
- the filter particle packing density is between approximately 0.2 g/cm 3 and approximately 11 g/cm 3 and more preferably between approximately 0.2 g/cm 3 and approximately 1.5 g/cm 3 and depends on the composition of the core (a filter particle packing density of 0.2 g/cm 3 corresponds to charcoal while 11 g/cm 3 corresponds to metal).
- the plurality of distinct GO filter particles 12 making up the layer of GO 7 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 4 millimeters and are packed into the filtering unit 5 at a filter particle packing density between approximately 0.2 g/cm 3 and approximately 11 g/cm 3 .
- the plurality of distinct GO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.2 g/cm 3 and approximately 1.5 g/cm 3 .
- the plurality of distinct GO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 4 millimeters and are packed into the filtering unit 5 at a filter particle packing density between approximately 0.2 g/cm 3 and approximately 11 g/cm 3 . In yet another embodiment of the present disclosure, the plurality of distinct GO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.2 g/cm 3 and approximately 1.5 g/cm 3 .
- an embodiment of the present disclosure shows a non-porous structural membrane 8 with a layer of polar GO 7 together making up the filter medium 4 wherein the polar GO filter medium 4 is configured as a GO coating on at least one surface of a non-porous structural membrane 8 .
- the non-porous structural membrane 8 may be graphitic or non-graphitic and may be inert.
- the layer of polar GO 7 may be at least approximately 1 micrometer and may be between approximately 1 micrometer and approximately 1 millimeter. More preferably, the thickness of the layer of GO 7 is between approximately 1 micrometer and approximately 50 micrometers.
- the non-porous structural membrane 8 may generally be made of glass, polymer, metal, plastic, or combinations thereof and more specifically be a glass slide, a polystyrene slide, a silicon wafer, or combinations thereof.
- an embodiment of the present disclosure shows a porous filtering membrane 10 , configured to remove non-biological impurities from polar solvents such as water, and comprising a layer of polar GO 7 together making up the filter medium 4 wherein the polar GO filter medium 4 is configured as a GO coating on at least one surface of the porous filtering membrane 10 .
- the porous filtering membrane 10 may be graphitic or non-graphitic and may be inert.
- the layer of polar GO 7 may be at least approximately 1 micrometer and may be between approximately 1 micrometer and approximately 1 millimeter. More preferably, the thickness of the GO layer 7 is between approximately 1 micrometer and approximately 50 micrometers.
- the non-porous structural membrane 8 may generally be made of metal, plastic, paper, polymer, ceramic, carbon, or combinations thereof.
- the non-porous structural membrane 8 may be planar and may comprise alumina or charcoal.
- the porous filtering membrane is configured to filter polar solvents.
- the method includes utilizing a collection device comprising a fluid inlet 16 , a filtrate outlet 18 , a sampling chamber 17 , and a GO sampling medium 22 .
- the fluid inlet 16 and the filtrate outlet 18 are in fluid communication with the sampling chamber 17 .
- the sampling medium 22 which resides in the sampling chamber 17 , is made up of polar GO comprising at least one reactive oxygen functional group.
- the GO has a polarity exceeding approximately 0.25 on the E T N scale. In other embodiments of the present disclosure, the GO has a polarity exceeding approximately 0.5 on the E T N scale or a polarity exceeding approximately 0.65 on the E T N scale.
- the GO has been functionalized so that the GO includes at least one reactive oxygen functional group and has an oxygen content exceeding approximately 15%.
- the reactive oxygen functional group may be an ether, hydroxyl, epoxide, ketone, carbonyl, carboxyl groups, or combinations thereof.
- the method further comprises exposing the environmental sample to the polar GO sampling medium 22 to trap impurities 40 residing in the environmental sample in the polar GO sampling medium 22 .
- the trapped impurities 40 may then be released from the polar GO sampling medium and analyzed or stored for future use.
- the method further comprises analyzing the trapped impurities 40 in situ, without releasing the impurities from the polar GO sampling medium 22 .
- the trapped impurities 40 include microorganisms, cells, or combinations thereof.
- the microorganisms include microbes, bacteria, fungi, yeast, algae, or combinations thereof.
- the environmental sample may be a sample of air, water, soil, or combinations thereof or may be saliva, sweat, blood, bodily secretions, or combinations thereof and may be in the form of a solid surface, liquid surfaces, a liquid, a food sample or combinations thereof.
- Organic Solvent Sterilization and Purification Application The use of organic solvents in the pharmaceutical and biomedical industry, and in biochemistry, biology and biomolecular laboratories and hospitals is ubiquitous. For multiple applications, sterile solvents that are free of microorganisms are required. However, the sterilization of organic solvents is a difficult and cumbersome process relying on the use of small pore size filters (0.22 to 0.45 ⁇ m) that presents a barrier to solvent flow. Other sterilization procedures, such as autoclaving or UV irradiation, cannot be applied to solvents because their properties can deteriorate and may be hazardous to workers.
- GO media can be used to form columns, filters, coatings and films that can be used to sterilize organic solvents with ease.
- the GO filtering matrix provides a simple sterilization procedure, based on binding and trapping the microbial cells, that dramatically reduces the time and pressures required for filtration and sterilization of organic solvents, solvent mixtures and fuels while being very user-friendly.
- graphene oxide matrices can be applied in the sampling and collection of microorganisms (bacteria, fungi, yeast, algae, and other) and cells from different environmental samples such as air, water, soil, solid and liquid surfaces; medical samples including saliva, sweat, blood, bodily secretions and fluids; food samples, and others.
- microorganisms bacteria, fungi, yeast, algae, and other
- the GO matrix can be treated to recover intact viable cells or nucleic acids, proteins, and biomolecules for analysis. Otherwise, the GO matrix with the attached cells can be stored for future analysis.
- GO Fuel Purification/Sterilization Media.
- GO can be applied as a sole column or filter matrix, in combination with a support media, or in combination with existing fuel and lubricant filters for the removal of microorganisms from these fluids.
- the purpose of the GO media will be the removal of biological contaminants, including bacteria, fungi, yeast, algae, and other cells.
- Filters are commonly used in the automotive, aircraft, watercraft and power generation industry for removal of different impurities from fuel, oil, lubricants and hydraulic fluids. However, these filters fail to remove biological contaminants from these fluids. GO can be used as a part of these existing filters to remove microorganisms and cells from fluids.
- Water Purification Media GO in the form of columns, filters, films, powder, suspensions and as a part of existing filters may be combined with silver and other antimicrobial agents to be used in water purification applications.
- GO-based materials do not present antimicrobial or cytotoxic characteristics but instead actively promote cellular growth and differentiation. In fact, GO does not have intrinsic antibacterial, bacteriostatic, or cytotoxic properties in either bacteria or mammalian cells, but rather acts as a general enhancer of cellular growth by increasing cell attachment and proliferation. GO may be used as a scaffold for cell surface attachment and proliferation.
- Jet-A fuel samples were inoculated with bacteria and then subjected to filtration and characterized for filtration efficiency.
- Biomolecular approaches including quantitative real-time PCR (qPCR), cell-based colony counting, scanning electron microscopy (SEM), and fluorescent microscopy, were applied to demonstrate the efficiency, functionality and mode of action of the GO filter.
- GO was synthesized using a modified version of the Hummers method.
- Filter columns were developed by packing 32 mg and 260 mg of thin, flakes of GO in to 0.5 and 2.5 ml plastic syringe casings, respectively.
- the 32 and 260 mg GO columns were tested for their ability to remove Gram positive and Gram negative bacteria from 7 ml and 7,000 ml of jet fuel, respectively.
- To reduced variability in the tests and maintain constant flow rates the 260 mg GO columns were tested as part of an apparatus that allowed using the laboratory vacuum system (50 kPa). For the 32 mg column, flow pressure was provided by a mechanical pipette.
- the GO was then analyzed using fluorescent microscopy and SEM to determine if bacteria cells attached to the GO matrix and if the cells retained viability. It was determined that cells attached to the GO but that the interaction of the cells with GO did not lead to cell lysis. SEM was performed to confirm the presence of intact bacteria on the surface and within the GO matrix. At a magnification of 4500 ⁇ , the SEM showed a large number of bacteria attached to the GO matrix. At higher magnification, it was observed that individual cells were strongly attached to the GO surface. The interaction of bacteria with the GO surface appeared to induce morphological changes particularly in the bacteria cell wall and cell membrane. The highest magnification SEM showed that while cells did change morphology in comparison to untreated bacteria, the cells seemed to maintain their integrity. These results further confirmed that GO lacks antibacterial, cytotoxic, and bacteriostatic properties.
- Characterization of cell binding strength to GO The strength of the cell binding to the GO filter matrix was next tested. In order to evaluate binding strength, cell recovery following binding to the GO matrix using mild or harsh DNA extraction protocols was assessed. If the cells attached strongly to the GO matrix, the DNA yield under the mild conditions would be low, but under harsh conditions, yields comparable to the glass wool (GW) control matrix were expected. The results demonstrated this trend and confirmed that under mild treatment, the amount of DNA recovered (2.15 ⁇ 10 7 gene copies/ml) from the GO matrix was 47 times lower than the DNA level recovered from GW (1.02 ⁇ 10 9 gene copies/ml).
- the lower concentration of DNA recovered from GO under mild treatment in comparison to GW samples is an indication that the mild treatment was not capable of releasing cells that were tightly bound to the GO matrix. However, this treatment was sufficient to recover high DNA concentration from the GW matrix which did not induce strong attachment. Higher DNA concentration in the GW samples also indicated that the low speed centrifugation did not precipitate free bacterial cells in solution. However, cells strongly attached to GO co-precipitated together with the GO matrix. Detection of low levels of DNA in the GO samples under mild treatment can be explained by the release of free DNA from the GO matrix after hydration with aqueous media.
- GO was synthesized using a modified Hummers method.
- Ag-GO was prepared using a sonochemical method as follows. 50 mg of GO, 25 mg of silver acetate, and 15 ml of DMF were mixed in a three arm sonochemical flask (Sonics Inc., Suslick flask). The mixture was sonicated at 37% amplitude and 20 KHz for 20 minutes using a pulsed (1 second on, 1 second off) procedure. After the sonication, the solution turned black and was stable for a few hours without any noticeable precipitation. In the process of recovering Ag-GO, the mixture was transferred to a round-bottom flask and DMF was removed using a rotary evaporator. The remaining solid material was transferred to a centrifuge tube where it was washed with DI water and ethanol five times, respectively. The ethanol was dried by blowing nitrogen across the surface of the solution and the final Ag-GO product was recovered as a black powder.
- GO suspension was obtained by sonication of the obtained graphite oxide powder in water (approximately 250 ⁇ g/mI). 40 ⁇ l of GO suspension or about 10 ⁇ g of GO per slide was spotted using a micropipette onto a glass slide and the slide was allowed to evaporate in a fume hood to result in a thin GO film on the slide. For the blank control slide, ultrapure sterile water was spotted and allowed to dry. Glass slides with or without GO film were placed into a culture dish (10 cm in diameter) and treated with UV irradiation for 1 hour.
- PVDF filters 0.22 ⁇ m PVDF filters were coated with a 100 and 300 ⁇ l GO suspension containing 25 and 75 ⁇ g GO, respectively. Filter coating took place by releasing the GO solution evenly using a circular motion from a micropipette. The GO-coated filters were allowed to dry in the laminal flow hood under sterile conditions. Once dried, the GO-coated filters were used in the growth bioassay experiments.
- Real-time PCR analysis was performed on bacterial genomic DNA samples using the CFX real-time PCR system (BioRad, Hercules, Calif.) with a two-step amplification program with post-amplification melt curve analysis. 16S gene-specific real-time PCR primers and synthetic oligonucleotide standard were developed. The synthetic oligonucleotide was serial-diluted from 1 ⁇ 10 8 copies/ ⁇ I to 1 ⁇ 104 copies/ ⁇ l and used as standards for absolute quantification purposes. Real-time PCR sample reactions were produced by preparing a master mix containing the 16S gene-specific primers, BioRad SYBR Green SuperMix, water, and the appropriate sample DNA.
- samples containing 5 ml Luria Bertani (LB) nutrient broth in 15 ml conical tubes were amended with GO to a final concentration of 25 ⁇ g/ml and then inoculated with E. coli bacterial cells to a concentration of 0.03 OD.
- the experimental control was produced by inoculating E. coli to 0.03 OD in 5 ml LB broth without GO.
- a minimum of triplicate reactions of each condition were incubated for 16 hours at 37° C., and then examined for bacteria growth. Surprisingly, the culture tubes containing GO did not visually show any apparent reduction in bacterial growth.
- EPS extracellular polymeric substance
- GO inherently possessed antibacterial or bacteriostatic activity bacterial and mammalian cellular growth in the presence and absence of GO materials was determined by the development of carefully designed cell growth bioassays along with the use of quantitative real-time PCR (qPCR) analysis to accurately determine the cell number and the effect of GO on microbial proliferation. It was shown that GO materials do not adversely impact microbial and mammalian cell growth. Furthermore, GO materials tend to produce a dramatic increase in microbial and mammalian cell proliferation, indicating that GO is neither a bactericidal nor bacteriostatic material, but instead is a general growth enhancer that acts as a scaffold for cell surface attachment and proliferation. This is the first time that it has been conclusively demonstrated that GO does not have intrinsic antibacterial properties and cytotoxic properties.
- qPCR quantitative real-time PCR
- sterile PVDF filters with 0 (neat), 100, and 300 ⁇ l of a 250 ⁇ g/ml colloidal suspension of GO, equal to 0, 25, and 75 ⁇ g GO per filter. Filters were allowed to dry and were then inoculated with bacteria by submerging into a solution containing E. coli at a concentration of 1 ⁇ 106 cells/mL for 1 minute. The filters were recovered, allowed to dry, placed onto a sterile culture plate, and then incubated for 18 hours at 37° C. After the incubation period pictures were taken and genomic DNA was extracted from each of the filters for further analysis.
- qPCR quantitative real-time PCR
- This type of analysis provided the number of copies of the 16S rrn gene in the sample, which was then used to determine the exact number of cells by dividing the obtained sample gene copy number by the number of 16S rrn genes found in the E. coli cell; seven copies of the 16S rrn gene are found per E. coli cell.
- the qPCR results showed that the bacteria levels in filters containing GO was higher than that in the filters without GO.
- the filters containing 25 ⁇ g of GO had double the amount of bacteria than the neat filter, while the filter covered with 75 ⁇ g of GO had three times more cells that the neat filter.
- GO films were placed onto culture plates that were previously inoculated with 1 ⁇ 10 6 E. coli cells per plate. Then, 1 ⁇ 10 6 E. coli cells were directly inoculated on top of the film pieces and allowed to dry. The plates were incubated for 18 hours at 37° C. After the incubation period, genomic DNA was extracted from each of the filters for further analysis. The purpose of this type of inoculation was to observe growth over the GO film and also to determine if any growth inhibition zone was formed around the GO film. These inhibition areas would indicate that the material has some toxic effect on the bacteria.
- Results showed that growth inhibition zones were not detected in the plate containing either GO film or filter paper. However, Ag-decorated GO showed large growth inhibition zones characterized by a clear area with no cell growth. These results clearly demonstrate that GO does not have antimicrobial effects capable of producing a toxic effect in the area surrounding the GO film. By decorating GO material with silver it was further demonstrated that GO materials are functional and capable of supporting common antimicrobial materials including silver.
- qPCR performed to determine the growth level over the different films revealed that GO paper supported bacteria growth more efficiently than a PVDF filter.
- the results showed that the surface of the GO film contained 9.5 ⁇ 10 6 cells while the filter paper had 7.5 ⁇ 10 9 cells.
- the cell level over the Ag-GO paper was determined to be 3.5 ⁇ 10 4 cells, which was lower than the initial inoculation level of 1 ⁇ 10 6 cells; indicating that bacteria cell death was achieved. These results do not indicate any adverse or toxic effect of GO towards bacteria.
- GO promotes bacterial growth by enhancing attachment, proliferation, and biofilm formation.
- Control glass slides and glass slides coated with 10 ⁇ g of GO were placed onto a culture dish to which culture media and 6 ⁇ 10 5 mammalian colorectal adenocarcinoma HT-29 cells were added. The cells were allowed to attach and develop on the slides. At various time intervals, cell attachment was assessed by light microscopy. The results indicate that the mammalian cells attached more efficiently to the GO-coated glass slides and grew. The micrographs showed marked morphological changes and cell enlargement and spreading on the GO-coated glass slides, which are characteristic of effective cell attachment and cell growth.
- GO has no antibacterial properties. Furthermore, GO lacks any bacteriostatic property as shown by the prolific growth observed on all forms of GO tested. GO acts as an enhancer of life, increasing not only mammalian cell growth but also bacterial growth. In the past, several studies have shown that GO is noncytotoxic to mammalian cells, but that it somehow acts as an antibacterial material.
- the GO production process shown in an embodiment of this invention which includes long term dialysis, dilution, and sonication, takes great care in removing carryon impurities that could affect the properties of the material.
- references herein of a component of the present disclosure being “configured” in a particular way, to embody a particular property, or to function in a particular manner, are structural recitations, as opposed to recitations of intended use. More specifically, the references herein to the manner in which a component is “configured” denotes an existing physical condition of the component and, as such, is to be taken as a definite recitation of the structural characteristics of the component.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Filtering Materials (AREA)
Abstract
Description
- The present application is filed under 35 U.S.C. 111(a) as a continuation of International Patent Application No. PCT/US2013/045378, filed Jun. 12, 2013, which international application designates the United States and claims the benefit of U.S. Provisional Application Ser. No. 61/658,483, filed Jun. 12, 2012.
- The present invention was federally funded, in part, by the Air Force Research Laboratory Fuels and Energy Branch—contract number FA8650-10-2-2934. The government has certain rights in the invention.
- The present invention relates generally to the application of graphene oxide materials to the filtration of fluids.
- Microorganisms are known to colonize and biodeteriorate hydrocarbon fuels. Multiple species of bacteria have been isolated from fuel storage tanks, pipelines, and aircraft wing tanks. Some of the problems associated with microbial growth in aviation fuels include wing and storage tank corrosion, fuel pump failures, filter plugging, injector fouling, topcoat peeling, engine damage, and deterioration of fuel chemical properties and quality. Extensive microbial growth and biofilm formation can lead to costly and disruptive damage to fuel systems and aircraft hardware.
- Currently, prevention of fuel biodeterioration relies on housekeeping practices including removal of water from fuel using fuel-water coalescers and filtration of coarse particulates. Filtration is used to remove coarse impurities. However, even the best fuel filters are incapable of completely filtering out particles smaller than 10 μm in diameter; microorganisms can range from less than a micrometer to a few micrometers in size. Due to their small pore size, 0.22-0.45 μm filters are difficult to use because they present a strong barrier to fuel flow. The removal of free water from fuel also has a large impact on prevention of biodeterioration, or biofouling, given that microorganisms require water to grow. Additionally, military jet fuels are treated with an antimicrobial additive known as diethylene glycol mono-methyl ether (DiEGME), to prevent microbial growth and formation of biofilms. However, the use of this additive is expensive and may present adverse effects to the environment. The present disclosure is directed toward the effective filtration, purification, and prevention of biodeterioration of liquids, including fuels, using graphene oxide (GO).
- In accordance with one embodiment of the present disclosure, a filter or collection device comprising a fluid inlet, a filtrate outlet, a filtering chamber, and a filter medium is described. The fluid inlet and the filtrate outlet are in fluid communication with the filtering chamber. The filter medium, which resides in the filtering chamber, comprises polar graphene oxide and has at least one reactive oxygen functional group. The polarity of the polar graphene oxide exceeds approximately 0.25 on the ET N scale while comprising an oxygen content exceeding approximately 15%.
- In accordance with another embodiment of the present disclosure, a filter or collection device comprises a polar graphene oxide filter medium characterized by a polarity exceeding approximately 0.25 on the ET N scale and an oxygen content exceeding that of reduced graphene oxide.
- In accordance with yet another embodiment of the present disclosure, a system for filtering fluids comprising a target fluid fluidly coupled to a target fluid inlet is described. The system comprises a fluid inlet, a filtrate outlet, a filtering chamber, and a filter medium. The filter medium, which resides in the filtering chamber, comprises polar graphene oxide and has at least one reactive oxygen functional group. The polarity of the polar graphene oxide filter medium exceeds approximately 0.25 on the ET N scale while comprising an oxygen content exceeding approximately 15%.
- In accordance with yet another embodiment of the present disclosure, a method for sampling impurities in an environmental sample utilizing a collection device is described. The collection device comprises a fluid inlet, a filtrate outlet, a sampling chamber, and a graphene oxide sampling medium. The fluid inlet and the filtrate outlet are in fluid communication with the sampling chamber within which the sampling medium resides. The sampling media comprises polar graphene oxide comprising at least one reactive oxygen functional group and is characterized by a polarity exceeding approximately 0.25 on the ET N scale and an oxygen content exceeding approximately 15%. The method further comprises exposing the environmental sample to the polar graphene oxide sampling medium such that the polar graphene oxide sampling medium traps impurities residing in the environmental sample.
- The following detailed description of the preferred embodiments of the present invention can best be understood when read in conjunction with the following drawings:
-
FIGS. 1A-C and 2A-D show possible structures of GO; -
FIG. 3 is a schematic view of a system for filtering fluids comprising a filter or collection device; -
FIG. 4 is a view of one embodiment of the present disclosure showing a GO coating surrounding a structural core; -
FIG. 5 is a view of one embodiment of the present disclosure showing a GO coating on a non-porous structural membrane; -
FIG. 6 is a view of one embodiment of the present disclosure showing a GO coating on a filtering membrane; -
FIG. 7 is a view of one embodiment of the present disclosure showing a filtering chamber comprising GO particles; and -
FIG. 8 is a view of one embodiment of the present disclosure showing a collection device for environmental sampling. - GO, a nanomaterial sheet formed by monolayers of functionalized carbon atoms arranged in thick honeycomb arrays, is an excellent material for many applications. The presence of reactive hydroxyl, epoxyl, and carboxyl functional groups on the surface of GO provide physical properties including high solubility in polar solvents, good colloidal properties, low production costs, low toxicity, and a large surface area which can be decorated with antimicrobial agents including nanosilver. The degree of surface functionalization imparted to the GO during oxidation determines the solubility of GO in water. Further, while aqueous solutions strongly interact with GO, organic solvents such as jet fuel tend to be repelled by GO.
- Applications for GO include use in water, fuel, and solvent microbial purification; single-step kits for rapid extraction and purification of nucleic acids (DNA, RNA), proteins, and cellular metabolites from eukaryotic and prokaryotic cells; surface coatings that inhibit bacteria and virus growth and contamination; encapsulation of high value cell lines and organisms to protect cells and increase product yield. As GO has been shown to promote the attachment of prokaryotic and eukaryotic cells and to enhance cell attachment, differentiation, and proliferation, GO may serve as a coating for conventional tissue culture matrices, as culture media additives, and as free-standing film matrices or porous gel-like structures for cell and tissue growth. GO has also shown promise in the biomedical field as it promotes the attachment of drugs and antimicrobial agents and enhances the encapsulation of cells.
- GO-based filters may be used for the efficient removal (sterilization) of microorganisms from organic and aqueous liquids; high volume rate filtration due to low pressure buildup (backpressure); and the removal of small quantities of free water from fuels and organic solvents. To prevent biodeterioration of fuels, microorganisms must be removed from fuel before it is stored in tanks and aircrafts. With the development of new biofuels that are more environmentally friendly, but that have a greater potential for biodegradation, new methods to prevent fuel biodeterioration is needed.
- In one embodiment of the present invention, GO filters for the purification and sterilization of fuels are disclosed. GO can be used as a filtration media for efficient removal of bacteria from hydrocarbon fuels. GO-based filters remove bacteria from fuel with an efficiency ≧99.9%. Additionally, these filters remove small amounts of water from fuels further demonstrating the applicability of GO filters to serve as a last stage water removal system in fuel storage applications; free water present in fuel can lead to engine malfunction due to freezing and increased microbial growth. Furthermore, the GO filters allowed rapid flow of fuel with low resistance.
- Upon interaction with GO, bacteria cells rapidly and irreversibly attach to the GO. Scanning electron microscopy (SEM) and fluorescent microscopy studies confirm that GO preparations lack lytic and antibacterial activity; cells in contact with GO retain structural integrity. Additionally, GO has the ability to bind nanosilver (Ag) and increase antimicrobial activity against Gram negative and Gram positive bacteria, and has the ability to form free standing structures and films. These observations significantly increase our understanding of the biological properties of GO and provide new bioengineering applications in the area of fuels and organic solvents purification.
- Referring initially to
FIGS. 1A-C and 2A-D, possible structures of GO sheets are shown. As the detailed structure of GO is unclear and depends largely on the chemical preparation of GO, several models of the structure are shown. GO sheets comprise monolayers of carbon atoms that form dense honeycomb structures with unique characteristics. GO contains a range of reactive oxygen functional groups that facilitate the application of GO in bioengineering. The solubility of GO in solvents, especially water, is important for applications in bioengineering. The maximum solubility of GO in a solvent depends both on the solvent polarity and the extent of surface functionalization imparted during oxidation. The surface of GO, when made from the Hummer's method, has oxygen functional groups, such as hydroxyl, epoxyl and carboxyl, which enable GO to be readily dispersed in water. - Referring now to
FIG. 3 , an embodiment of the present disclosure including a system for filtering fluids comprising atarget fluid 30, flowing in direction A, and a filter orcollection device 20 comprising afluid inlet 1, a filtrate outlet 2, afiltering chamber 3, and afilter medium 4 is shown. Thetarget fluid 30 is fluidly coupled to thefluid inlet 1 and thefluid inlet 1 and the filtrate outlet 2 are in fluid communication with thefiltering chamber 3. Thefilter medium 4, which resides in thefiltering chamber 3, is made up of polar GO which may be flakes, a film, a powder, a solution, a suspension, or a GO coated substrate. The GO has a polarity exceeding approximately 0.25 on the ET N scale. In other embodiments of the present disclosure, the GO has a polarity exceeding approximately 0.5 on the ET N scale or a polarity exceeding approximately 0.65 on the ET N scale. - The
target fluid 30 may contain DNA, RNA, microorganisms or cells which may be selected from microbes, bacteria, fungi, yeast, algae, or combinations thereof. Thetarget fluid 30 may be a non-polar fluid or an organic solvent. The organic solvent may comprise hydrocarbons, a hydrocarbon mixture, water, a hydrocarbon-water mixture, or combinations thereof or may be a combustible fuel such as kerosene, jet fuel, gasoline, diesel, or combinations thereof. Further, thefilter medium 4 may comprise a biocide or antimicrobial agent which, in some embodiments, is silver nanoparticles. - Further, the GO has been functionalized so that the GO includes at least one reactive oxygen functional group and has an oxygen content exceeding approximately 15%. The reactive oxygen functional group may be an ether, hydroxyl, epoxide, ketone, carbonyl, or carboxyl group, or combinations thereof.
- Here, oxygen content represents the atomic percent of oxygen atoms present in the polar GO filter medium 4 as approximately 66% carbon to approximately 33% oxygen corresponding to an atomic ratio of carbon to oxygen of approximately 2:1.
- In other embodiments of the present disclosure, the oxygen content of the polar GO may be between approximately 30% and approximately 33% or may be approximately 33%. In any event, the oxygen content and the polarity of the polar GO exceed that of reduced GO.
- In one embodiment, the filter or
collection device 20 is configured as a column filter. In another embodiment thefiltering chamber 3 may be a fuel storage vessel with thefilter medium 4 residing on interior walls of the fuel storagevessel filtering chamber 3. - Referring now to
FIG. 7 , showing an embodiment of the present disclosure, thefilter medium 4 may be made up of a plurality of distinct bulkGO filter particles 12 that are packed into afiltering unit 5 within thefiltering chamber 3. TheGO filter particles 12 may have a maximum cross-sectional dimension may be at least approximately 5 millimeters. The plurality of distinct bulkGO filter particles 12 are packed into thefiltering unit 5 at a filter particle packing density that permits gravity-induced fluid flow in the direction of Arrow A from thefluid inlet 1 to the filtrate outlet 2, through the packedGO filter particles 12 of thefilter medium 4 in thefiltering chamber 3. TheGO filter particles 12 are packed into the filtering unit at a filter particle packing density between approximately 0.01 g/cm3 and approximately 1 g/cm3 or more preferably at a filter particle packing density between approximately 0.1 g/cm3 and approximately 0.5 g/cm3. The plurality of distinct bulkGO filter particles 12 comprise a maximum cross-sectional dimension between approximately 100 micrometers and approximately 5 millimeters and are packed into the filtering unit at a filter particle packing density between approximately 0.01 g/cm3 and approximately 1 g/cm3. In another embodiment of the present invention, the plurality of distinct bulkGO filter particles 12 comprise a maximum cross-sectional dimension between approximately 100 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.1 g/cm3 and approximately 1 g/cm3. - Referring now to
FIG. 4 , an embodiment of the present disclosure showing thefilter medium 4 comprising astructural core 6 surrounded by a layer ofGO 7. Thestructural core 6 is non-graphitic and may be of any shape. It will be understood that while thestructural core 6 is depicted as a sphere, thestructural core 6 may be any regular or irregular shape. Thestructural core 6 may be a bead of glass, polymer, metal, ceramic, carbon, or combinations thereof and may be inert. - The layer of
polar GO 7 surrounding thestructural core 6 is made up of a plurality of distinctGO filter particles 12 and is at least approximately 1 micrometer in thickness and may be between approximately 1 micrometer and approximately 1 millimeter in thickness. In another embodiment of the present disclosure, the layer ofpolar GO 7 is between approximately 1 micrometer and approximately 50 micrometers. TheGO filter particles 12 comprise a maximum cross-sectional dimension of between approximately 200 micrometers and approximately 4 millimeters. In another embodiment of the present disclosure, it is contemplated that theGO filter particles 12 comprise a maximum cross-sectional dimension of at least approximately 200 micrometers and approximately 1 millimeter. - A plurality of
structural cores 6 surrounded by a layer ofGO 7 are packed into thefiltering unit 5. The packed plurality of GO coatedstructural cores 6 together make up thefilter medium 4 of thedevice 20. The plurality ofstructural cores 6 surrounded by a layer ofGO 7 are packed at a filter particle packing density selected to permit gravity-induced fluid flow from thefluid inlet 1 to the filtrate outlet 2, through the packed GO filter medium 4 in thefiltering chamber 3. The filter particle packing density is between approximately 0.2 g/cm3 and approximately 11 g/cm3 and more preferably between approximately 0.2 g/cm3 and approximately 1.5 g/cm3 and depends on the composition of the core (a filter particle packing density of 0.2 g/cm3 corresponds to charcoal while 11 g/cm3 corresponds to metal). - The plurality of distinct
GO filter particles 12 making up the layer ofGO 7 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 4 millimeters and are packed into thefiltering unit 5 at a filter particle packing density between approximately 0.2 g/cm3 and approximately 11 g/cm3. In yet another embodiment of the present disclosure, the plurality of distinctGO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.2 g/cm3 and approximately 1.5 g/cm3. In another embodiment of the present disclosure, the plurality of distinctGO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 4 millimeters and are packed into thefiltering unit 5 at a filter particle packing density between approximately 0.2 g/cm3 and approximately 11 g/cm3. In yet another embodiment of the present disclosure, the plurality of distinctGO filter particles 12 comprise a maximum cross-sectional dimension between approximately 200 micrometers and approximately 1 millimeter and are packed into the filtering unit at a filter particle packing density between approximately 0.2 g/cm3 and approximately 1.5 g/cm3. - Referring now to
FIG. 5 , an embodiment of the present disclosure shows a non-porousstructural membrane 8 with a layer ofpolar GO 7 together making up thefilter medium 4 wherein the polarGO filter medium 4 is configured as a GO coating on at least one surface of a non-porousstructural membrane 8. The non-porousstructural membrane 8 may be graphitic or non-graphitic and may be inert. The layer ofpolar GO 7 may be at least approximately 1 micrometer and may be between approximately 1 micrometer and approximately 1 millimeter. More preferably, the thickness of the layer ofGO 7 is between approximately 1 micrometer and approximately 50 micrometers. The non-porousstructural membrane 8 may generally be made of glass, polymer, metal, plastic, or combinations thereof and more specifically be a glass slide, a polystyrene slide, a silicon wafer, or combinations thereof. - Referring now to
FIG. 6 , an embodiment of the present disclosure shows aporous filtering membrane 10, configured to remove non-biological impurities from polar solvents such as water, and comprising a layer ofpolar GO 7 together making up thefilter medium 4 wherein the polarGO filter medium 4 is configured as a GO coating on at least one surface of theporous filtering membrane 10. Theporous filtering membrane 10 may be graphitic or non-graphitic and may be inert. The layer ofpolar GO 7 may be at least approximately 1 micrometer and may be between approximately 1 micrometer and approximately 1 millimeter. More preferably, the thickness of theGO layer 7 is between approximately 1 micrometer and approximately 50 micrometers. The non-porousstructural membrane 8 may generally be made of metal, plastic, paper, polymer, ceramic, carbon, or combinations thereof. The non-porousstructural membrane 8 may be planar and may comprise alumina or charcoal. The porous filtering membrane is configured to filter polar solvents. - Referring now to
FIG. 8 , a method for sampling impurities in an environmental sample is described. The method includes utilizing a collection device comprising afluid inlet 16, afiltrate outlet 18, asampling chamber 17, and a GO sampling medium 22. Thefluid inlet 16 and thefiltrate outlet 18 are in fluid communication with thesampling chamber 17. The sampling medium 22, which resides in thesampling chamber 17, is made up of polar GO comprising at least one reactive oxygen functional group. The GO has a polarity exceeding approximately 0.25 on the ET N scale. In other embodiments of the present disclosure, the GO has a polarity exceeding approximately 0.5 on the ET N scale or a polarity exceeding approximately 0.65 on the ET N scale. - Further, the GO has been functionalized so that the GO includes at least one reactive oxygen functional group and has an oxygen content exceeding approximately 15%. The reactive oxygen functional group may be an ether, hydroxyl, epoxide, ketone, carbonyl, carboxyl groups, or combinations thereof.
- The method further comprises exposing the environmental sample to the polar GO sampling medium 22 to trap
impurities 40 residing in the environmental sample in the polar GO sampling medium 22. The trappedimpurities 40 may then be released from the polar GO sampling medium and analyzed or stored for future use. In another embodiment of the present disclosure, the method further comprises analyzing the trappedimpurities 40 in situ, without releasing the impurities from the polar GO sampling medium 22. The trappedimpurities 40 include microorganisms, cells, or combinations thereof. The microorganisms include microbes, bacteria, fungi, yeast, algae, or combinations thereof. The environmental sample may be a sample of air, water, soil, or combinations thereof or may be saliva, sweat, blood, bodily secretions, or combinations thereof and may be in the form of a solid surface, liquid surfaces, a liquid, a food sample or combinations thereof. - The following examples are given to illustrate specific embodiments of the present invention and are in no way intended to limit the scope of the disclosure in this application.
- Organic Solvent Sterilization and Purification Application. The use of organic solvents in the pharmaceutical and biomedical industry, and in biochemistry, biology and biomolecular laboratories and hospitals is ubiquitous. For multiple applications, sterile solvents that are free of microorganisms are required. However, the sterilization of organic solvents is a difficult and cumbersome process relying on the use of small pore size filters (0.22 to 0.45 μm) that presents a barrier to solvent flow. Other sterilization procedures, such as autoclaving or UV irradiation, cannot be applied to solvents because their properties can deteriorate and may be hazardous to workers. GO media can be used to form columns, filters, coatings and films that can be used to sterilize organic solvents with ease. The GO filtering matrix provides a simple sterilization procedure, based on binding and trapping the microbial cells, that dramatically reduces the time and pressures required for filtration and sterilization of organic solvents, solvent mixtures and fuels while being very user-friendly.
- Environmental Sampling Media. Because GO presents a preferred surface for the attachment of cells, graphene oxide matrices can be applied in the sampling and collection of microorganisms (bacteria, fungi, yeast, algae, and other) and cells from different environmental samples such as air, water, soil, solid and liquid surfaces; medical samples including saliva, sweat, blood, bodily secretions and fluids; food samples, and others. Once the microorganism, cell, or virus has attached to the GO media and is trapped, the GO matrix can be treated to recover intact viable cells or nucleic acids, proteins, and biomolecules for analysis. Otherwise, the GO matrix with the attached cells can be stored for future analysis.
- Fuel Purification/Sterilization Media. GO can be applied as a sole column or filter matrix, in combination with a support media, or in combination with existing fuel and lubricant filters for the removal of microorganisms from these fluids. The purpose of the GO media will be the removal of biological contaminants, including bacteria, fungi, yeast, algae, and other cells.
- Microbial removal as part of existing filters. Filters are commonly used in the automotive, aircraft, watercraft and power generation industry for removal of different impurities from fuel, oil, lubricants and hydraulic fluids. However, these filters fail to remove biological contaminants from these fluids. GO can be used as a part of these existing filters to remove microorganisms and cells from fluids.
- Water Purification Media. GO in the form of columns, filters, films, powder, suspensions and as a part of existing filters may be combined with silver and other antimicrobial agents to be used in water purification applications.
- Cell Growth Promotion. GO-based materials do not present antimicrobial or cytotoxic characteristics but instead actively promote cellular growth and differentiation. In fact, GO does not have intrinsic antibacterial, bacteriostatic, or cytotoxic properties in either bacteria or mammalian cells, but rather acts as a general enhancer of cellular growth by increasing cell attachment and proliferation. GO may be used as a scaffold for cell surface attachment and proliferation.
- A GO filter for the removal of microorganisms from jet fuel is described. Jet-A fuel samples were inoculated with bacteria and then subjected to filtration and characterized for filtration efficiency. Biomolecular approaches, including quantitative real-time PCR (qPCR), cell-based colony counting, scanning electron microscopy (SEM), and fluorescent microscopy, were applied to demonstrate the efficiency, functionality and mode of action of the GO filter.
- GO was synthesized using a modified version of the Hummers method. Filter columns were developed by packing 32 mg and 260 mg of thin, flakes of GO in to 0.5 and 2.5 ml plastic syringe casings, respectively. The 32 and 260 mg GO columns were tested for their ability to remove Gram positive and Gram negative bacteria from 7 ml and 7,000 ml of jet fuel, respectively. To reduced variability in the tests and maintain constant flow rates the 260 mg GO columns were tested as part of an apparatus that allowed using the laboratory vacuum system (50 kPa). For the 32 mg column, flow pressure was provided by a mechanical pipette.
- The GO was then analyzed using fluorescent microscopy and SEM to determine if bacteria cells attached to the GO matrix and if the cells retained viability. It was determined that cells attached to the GO but that the interaction of the cells with GO did not lead to cell lysis. SEM was performed to confirm the presence of intact bacteria on the surface and within the GO matrix. At a magnification of 4500×, the SEM showed a large number of bacteria attached to the GO matrix. At higher magnification, it was observed that individual cells were strongly attached to the GO surface. The interaction of bacteria with the GO surface appeared to induce morphological changes particularly in the bacteria cell wall and cell membrane. The highest magnification SEM showed that while cells did change morphology in comparison to untreated bacteria, the cells seemed to maintain their integrity. These results further confirmed that GO lacks antibacterial, cytotoxic, and bacteriostatic properties.
- Characterization of cell binding strength to GO: The strength of the cell binding to the GO filter matrix was next tested. In order to evaluate binding strength, cell recovery following binding to the GO matrix using mild or harsh DNA extraction protocols was assessed. If the cells attached strongly to the GO matrix, the DNA yield under the mild conditions would be low, but under harsh conditions, yields comparable to the glass wool (GW) control matrix were expected. The results demonstrated this trend and confirmed that under mild treatment, the amount of DNA recovered (2.15×107 gene copies/ml) from the GO matrix was 47 times lower than the DNA level recovered from GW (1.02×109 gene copies/ml). The lower concentration of DNA recovered from GO under mild treatment in comparison to GW samples is an indication that the mild treatment was not capable of releasing cells that were tightly bound to the GO matrix. However, this treatment was sufficient to recover high DNA concentration from the GW matrix which did not induce strong attachment. Higher DNA concentration in the GW samples also indicated that the low speed centrifugation did not precipitate free bacterial cells in solution. However, cells strongly attached to GO co-precipitated together with the GO matrix. Detection of low levels of DNA in the GO samples under mild treatment can be explained by the release of free DNA from the GO matrix after hydration with aqueous media.
- Under harsh treatment the concentration of DNA recovered from the GO matrix (1.02×109 gene copies/ml) was similar to the levels recovered from GW under mild (1.02×109 gene copies/ml) and harsh treatments (1.40×109 gene copies/ml). These results indicate that by lysing the cells directly while they are still attached to the GO matrix, DNA is recovered in similar levels to those of the control samples. This revealed that once cells have attached to GO is very difficult to release them by mechanical treatment. This property is important in filter development because it will guarantee that the cells cannot be released from the filter once they are trapped by the filter.
- Currently, there is no easy procedure to remove microorganisms from small and large volumes of fuel and other organic solvents. Currently the only way to sterilize small volumes (1-5 liters) of fuels and other organic solvents for laboratory experimentation require filtration through a 0.22 μM filter. This process is very cumbersome and can take over a half an hour per liter even with the application of high vacuum pressure. This type of approach is not feasible for the treatment and sterilization of large fuel volumes such as those moved through a fuel infrastructure. Thus, GO filters are able to filter similar amounts of fuel in a fraction of the time with minimal pressure buildup. This presents the possibility to scale up the filtration process to handle much larger volumes and is a true solution to the issue of fuel microbial contamination and deterioration.
- GO was synthesized using a modified Hummers method. Ag-GO was prepared using a sonochemical method as follows. 50 mg of GO, 25 mg of silver acetate, and 15 ml of DMF were mixed in a three arm sonochemical flask (Sonics Inc., Suslick flask). The mixture was sonicated at 37% amplitude and 20 KHz for 20 minutes using a pulsed (1 second on, 1 second off) procedure. After the sonication, the solution turned black and was stable for a few hours without any noticeable precipitation. In the process of recovering Ag-GO, the mixture was transferred to a round-bottom flask and DMF was removed using a rotary evaporator. The remaining solid material was transferred to a centrifuge tube where it was washed with DI water and ethanol five times, respectively. The ethanol was dried by blowing nitrogen across the surface of the solution and the final Ag-GO product was recovered as a black powder.
- In the film (paper) preparation of GO and Ag-GO, a suspension of GO or Ag-GO in DMF (0.7 mg/ml, 19 ml) was filtered through a PVDF membrane (Whatman, 0.45 pm, 47 nm diameter). The thin layer of the film formed on the membrane was then subsequently peeled away.
- GO suspension was obtained by sonication of the obtained graphite oxide powder in water (approximately 250 μg/mI). 40 μl of GO suspension or about 10 μg of GO per slide was spotted using a micropipette onto a glass slide and the slide was allowed to evaporate in a fume hood to result in a thin GO film on the slide. For the blank control slide, ultrapure sterile water was spotted and allowed to dry. Glass slides with or without GO film were placed into a culture dish (10 cm in diameter) and treated with UV irradiation for 1 hour.
- 0.22 μm PVDF filters were coated with a 100 and 300 μl GO suspension containing 25 and 75 μg GO, respectively. Filter coating took place by releasing the GO solution evenly using a circular motion from a micropipette. The GO-coated filters were allowed to dry in the laminal flow hood under sterile conditions. Once dried, the GO-coated filters were used in the growth bioassay experiments.
- Real-time PCR analysis was performed on bacterial genomic DNA samples using the CFX real-time PCR system (BioRad, Hercules, Calif.) with a two-step amplification program with post-amplification melt curve analysis. 16S gene-specific real-time PCR primers and synthetic oligonucleotide standard were developed. The synthetic oligonucleotide was serial-diluted from 1×108 copies/μI to 1×104 copies/μl and used as standards for absolute quantification purposes. Real-time PCR sample reactions were produced by preparing a master mix containing the 16S gene-specific primers, BioRad SYBR Green SuperMix, water, and the appropriate sample DNA.
- To determine the effect of GO on bacterial growth, samples containing 5 ml Luria Bertani (LB) nutrient broth in 15 ml conical tubes were amended with GO to a final concentration of 25 μg/ml and then inoculated with E. coli bacterial cells to a concentration of 0.03 OD. The experimental control was produced by inoculating E. coli to 0.03 OD in 5 ml LB broth without GO. A minimum of triplicate reactions of each condition were incubated for 16 hours at 37° C., and then examined for bacteria growth. Surprisingly, the culture tubes containing GO did not visually show any apparent reduction in bacterial growth. Furthermore, they appeared more turbid than the control culture and a dense dark precipitate was observed at the bottom of the tube. The dark precipitate was not produced in the control cultures without GO. Growth level in the bacteria cultures was determined by measuring the absorbance at 600 nm. Samples were taken from the supernatant without disturbing the dark precipitate containing GO. The results showed that the GO-containing samples achieved an average absorbance of 1.7 in 16 hours of incubation while the bacteria growing in LB broth only achieved an absorbance of 1.3. These results indicated that bacteria in the presence of GO grew faster than bacteria in LB media and was able to achieve cell saturation sooner. The dark precipitate observed in samples containing GO may have been responsible for enhancing bacterial growth in the media, or harboring bacterial growth itself. To address this, samples of the dark precipitate were analyzed using scanning electron microscopy.
- Scanning electron microscopy (SEM) analysis showed that the dark precipitate was formed by a thick bacterial biofilm containing a large mass of aggregated cells and extracellular polymeric material. A negative control reaction containing LB broth and GO, but no bacteria, showed the formation of lower density dark aggregates that did not precipitate to the bottom of the culture tube. When a colloidal suspension of GO in water is added to a solution media containing salts, the colloidal suspension aggregates and could falloff suspension producing low density aggregates. It is possible that precipitation required bacterial growth. The massive amount of cells observed in the biofilm indicate that there is a direct effect of GO in bacteria proliferation when colloidal GO is added to liquid media. Results showed that the precipitation of GO in the culture media may act as a scaffold for bacterial attachment, proliferation, and biofilm formation. Studies have shown that carbon nanomaterials could act as attachment surfaces where small colonies grow around tubular carbon nanostructures.
- Further, precipitated GO induced massive cell growth, aggregation and secretion of extracellular polymeric substance (EPS). In the SEM images it was possible to observe void areas in the EPS with the shape of rod bacteria. This indicates that bacteria were directly responsible for secreting the EPS. The rod-shape voids observed may be due to the process of bacteria dispersal; a process in which bacteria evacuate the interior of biofilms due to competition or lack of nutrients, leaving behind hollow, shell-like structures.
- To determine if GO inherently possessed antibacterial or bacteriostatic activity, bacterial and mammalian cellular growth in the presence and absence of GO materials was determined by the development of carefully designed cell growth bioassays along with the use of quantitative real-time PCR (qPCR) analysis to accurately determine the cell number and the effect of GO on microbial proliferation. It was shown that GO materials do not adversely impact microbial and mammalian cell growth. Furthermore, GO materials tend to produce a dramatic increase in microbial and mammalian cell proliferation, indicating that GO is neither a bactericidal nor bacteriostatic material, but instead is a general growth enhancer that acts as a scaffold for cell surface attachment and proliferation. This is the first time that it has been conclusively demonstrated that GO does not have intrinsic antibacterial properties and cytotoxic properties.
- Bacterial growth on filters coated with 25 and 75 μg GO grew two to three-times better than on filters without GO. Closer analysis showed that bacteria were able to attach and proliferate preferentially in areas containing the highest GO levels. GO films failed to produce growth inhibition zones around them, indicating a lack of antibacterial properties. Also, bacteria was able to grow on GO films to 9.5×109 cells from an initial inoculation of 1.0×106, indicating that GO materials also lack bacteriostatic activity. Furthermore, it is shown that GO materials can be functionalized with antimicrobial agents, including silver nanoparticles, to inhibit proliferation of microbial pathogens such as bacteria and viruses while retaining the beneficial characteristics that promote mammalian cell growth and differentiation. Thus, silver-coated GO films were able to produce clearing zones and cell death.
- To determine the effect of GO when coated onto a surface, we coated sterile PVDF filters with 0 (neat), 100, and 300 μl of a 250 μg/ml colloidal suspension of GO, equal to 0, 25, and 75 μg GO per filter. Filters were allowed to dry and were then inoculated with bacteria by submerging into a solution containing E. coli at a concentration of 1×106 cells/mL for 1 minute. The filters were recovered, allowed to dry, placed onto a sterile culture plate, and then incubated for 18 hours at 37° C. After the incubation period pictures were taken and genomic DNA was extracted from each of the filters for further analysis.
- Bacteria growth on filters with or without GO was determined by quantitative real-time PCR (qPCR) analysis of the bacteria genomic DNA. Bacteria growth was observed with the naked eye in all samples, but the filters containing GO presented large bacteria colonies around specific areas that seemed to contain more GO. qPCR was chosen over other methods of analysis because it allows precise determination of the level of cellular growth. To achieve cellular quantification, a qPCR assay that targeted the 16S ribosomal RNA (rrn) gene, a ubiquitous gene in all bacteria, and a synthetic oligonucleotide standard for quantification that spanned the amplicon region were used. This type of analysis provided the number of copies of the 16S rrn gene in the sample, which was then used to determine the exact number of cells by dividing the obtained sample gene copy number by the number of 16S rrn genes found in the E. coli cell; seven copies of the 16S rrn gene are found per E. coli cell. The qPCR results showed that the bacteria levels in filters containing GO was higher than that in the filters without GO. The filters containing 25 μg of GO had double the amount of bacteria than the neat filter, while the filter covered with 75 μg of GO had three times more cells that the neat filter. These results indicate that GO not only lacks antimicrobial properties, but that it actually enhances microbial growth when coated onto another surface.
- Upon close inspection of the GO-coated and neat filters, interesting growth patterns that differentiate the GO-coated filters were observed. The GO-coated filters had easy to observe large cell colonies that followed a lined pattern around areas of higher GO content. These areas were observed in filters with 25 and 75 μg GO, but not in neat filters. Also, an area of dense bacterial growth in the sterile media was observed around all neat filter replicates. This halo of cells was not observed in any of the GO-coated filters. This demonstrated an inherent preference by bacteria to attach and grow in areas containing GO; especially those areas containing the highest GO levels.
- Go and Ag-GO films were analyzed using TEM and XRD analysis to determine the morphology, size distribution, and the crystal structure of Ag nanoparticles. TEM analysis clearly showed that the GO sheets were well decorated with Ag nanoparticles and size distribution analysis performed using TEM showed that the average size of Ag nanoparticles on the surface of GO was 8 nm. In addition, XRD analysis revealed that the silver-decorated graphene oxide (Ag-GO) spectrum closely matched the peaks seen in the face-centered-cubic silver (ICDD 00-004-0783). The effect of solid GO films on bacteria growth was studied by inoculating GO films, Ag-GO films, and filter pieces with E. coli bacteria. GO films were placed onto culture plates that were previously inoculated with 1×106 E. coli cells per plate. Then, 1×106 E. coli cells were directly inoculated on top of the film pieces and allowed to dry. The plates were incubated for 18 hours at 37° C. After the incubation period, genomic DNA was extracted from each of the filters for further analysis. The purpose of this type of inoculation was to observe growth over the GO film and also to determine if any growth inhibition zone was formed around the GO film. These inhibition areas would indicate that the material has some toxic effect on the bacteria.
- Results showed that growth inhibition zones were not detected in the plate containing either GO film or filter paper. However, Ag-decorated GO showed large growth inhibition zones characterized by a clear area with no cell growth. These results clearly demonstrate that GO does not have antimicrobial effects capable of producing a toxic effect in the area surrounding the GO film. By decorating GO material with silver it was further demonstrated that GO materials are functional and capable of supporting common antimicrobial materials including silver.
- qPCR performed to determine the growth level over the different films revealed that GO paper supported bacteria growth more efficiently than a PVDF filter. The results showed that the surface of the GO film contained 9.5×106 cells while the filter paper had 7.5×109 cells. The cell level over the Ag-GO paper was determined to be 3.5×104 cells, which was lower than the initial inoculation level of 1×106 cells; indicating that bacteria cell death was achieved. These results do not indicate any adverse or toxic effect of GO towards bacteria. Furthermore, GO promotes bacterial growth by enhancing attachment, proliferation, and biofilm formation.
- Testing of the role of GO film on mammalian cell attachment and proliferation was performed. Control glass slides and glass slides coated with 10 μg of GO were placed onto a culture dish to which culture media and 6×105 mammalian colorectal adenocarcinoma HT-29 cells were added. The cells were allowed to attach and develop on the slides. At various time intervals, cell attachment was assessed by light microscopy. The results indicate that the mammalian cells attached more efficiently to the GO-coated glass slides and grew. The micrographs showed marked morphological changes and cell enlargement and spreading on the GO-coated glass slides, which are characteristic of effective cell attachment and cell growth. However, very few cells became attached to and developed on the plain glass slides (the control) as observed by the round shape of cells, indicating lack of cellular enlargement and growth. These results clearly show that the GO film, beyond not exerting any cytotoxic effects on the cells, actually promotes mammalian cell attachment and proliferation. These results indicate that GO is a great support for mammalian cell attachment, growth, and proliferation. These results compare positively against carbon nanotube materials which have been shown to be cytotoxic at various concentrations.
- An embodiment of the present invention clearly demonstrates that GO has no antibacterial properties. Furthermore, GO lacks any bacteriostatic property as shown by the prolific growth observed on all forms of GO tested. GO acts as an enhancer of life, increasing not only mammalian cell growth but also bacterial growth. In the past, several studies have shown that GO is noncytotoxic to mammalian cells, but that it somehow acts as an antibacterial material. The GO production process shown in an embodiment of this invention, which includes long term dialysis, dilution, and sonication, takes great care in removing carryon impurities that could affect the properties of the material.
- While certain representative embodiments and details have been shown for purposes of illustrating the invention, it will be apparent to those skilled in the art that various changes may be made without departing from the scope of the invention. It is noted that recitations herein of “at least one” component, element, etc., should not be used to create an inference that the alternative use of the articles “a” or “an” should be limited to a single component, element, etc.
- It is noted that recitations herein of a component of the present disclosure being “configured” in a particular way, to embody a particular property, or to function in a particular manner, are structural recitations, as opposed to recitations of intended use. More specifically, the references herein to the manner in which a component is “configured” denotes an existing physical condition of the component and, as such, is to be taken as a definite recitation of the structural characteristics of the component.
- It is noted that terms like “preferably” and “commonly” when utilized herein, are not utilized to limit the scope of the claimed invention or to imply that certain features are critical, essential, or even important to the structure or function of the claimed invention. Rather, these terms are merely intended to identify particular aspects of an embodiment of the present disclosure or to emphasize alternative or additional features that may or may not be utilized in a particular embodiment of the present disclosure.
- For the purposes of describing and defining the present invention it is noted that the term “approximately” is utilized herein to represent the inherent degree of uncertainty that may be attributed to any quantitative comparison, value, measurement, or other representation. The term “approximately” is also utilized herein to represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue.
- Having described the subject matter of the present disclosure in detail and by reference to specific embodiments thereof, it is noted that the various details disclosed herein should not be taken to imply that these details relate to elements that are essential components of the various embodiments described herein, even in cases where a particular element is illustrated in each of the drawings that accompany the present description. Rather, the claims appended hereto should be taken as the sole representation of the breadth of the present disclosure and the corresponding scope of the various embodiments described herein. Further, it will be apparent that modifications and variations are possible without departing from the scope of the invention defined in the appended claims. More specifically, although some aspects of the present disclosure are identified herein as preferred or particularly advantageous, it is contemplated that the present disclosure is not necessarily limited to these aspects.
- It is noted that one or more of the following claims utilize the term “wherein” as a transitional phrase. For the purposes of defining the present invention, it is noted that this term is introduced in the claims as an open-ended transitional phrase that is used to introduce a recitation of a series of characteristics of the structure and should be interpreted in like manner as the more commonly used open-ended preamble term “comprising.”
Claims (46)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/940,612 US9403112B2 (en) | 2012-06-12 | 2013-07-12 | Graphene oxide filters and methods of use |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261658483P | 2012-06-12 | 2012-06-12 | |
PCT/US2013/045378 WO2013188521A1 (en) | 2012-06-12 | 2013-06-12 | Graphene oxide filters and methods of use |
US13/940,612 US9403112B2 (en) | 2012-06-12 | 2013-07-12 | Graphene oxide filters and methods of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/045378 Continuation WO2013188521A1 (en) | 2012-06-12 | 2013-06-12 | Graphene oxide filters and methods of use |
Publications (3)
Publication Number | Publication Date |
---|---|
US20130330833A1 US20130330833A1 (en) | 2013-12-12 |
US20140199777A2 true US20140199777A2 (en) | 2014-07-17 |
US9403112B2 US9403112B2 (en) | 2016-08-02 |
Family
ID=49715583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/940,612 Active 2034-04-11 US9403112B2 (en) | 2012-06-12 | 2013-07-12 | Graphene oxide filters and methods of use |
Country Status (1)
Country | Link |
---|---|
US (1) | US9403112B2 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606802A (en) * | 2015-01-22 | 2015-05-13 | 东南大学 | Filter element and preparation method and application thereof |
WO2016036888A1 (en) * | 2014-09-02 | 2016-03-10 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
US20170014778A1 (en) * | 2014-03-07 | 2017-01-19 | Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University) | Graphene oxide nanocomposite membrane for gas separation, reduced graphene oxide nanocomposite membrane, and method for manufacturing the same |
WO2017023380A1 (en) | 2015-08-05 | 2017-02-09 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
CN106830349A (en) * | 2016-12-28 | 2017-06-13 | 苏州大学 | Polymer-modified material of microorganism and preparation method thereof is wrapped up with the application in N, the treatment of N dimethylformamides |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
WO2017197205A1 (en) * | 2016-05-11 | 2017-11-16 | Massachusetts Institute Of Technology | Graphene oxide membranes and related methods |
US9833748B2 (en) | 2010-08-25 | 2017-12-05 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
WO2018111252A1 (en) * | 2016-12-14 | 2018-06-21 | South Dakota Board Of Regents | Graphene containing coatings, production process thereof and use |
US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
WO2019096066A1 (en) * | 2017-11-14 | 2019-05-23 | 中国农业科学院油料作物研究所 | Aflatoxin-adsorbing filter cloth, preparation method and use thereof |
US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
US10471199B2 (en) | 2013-06-21 | 2019-11-12 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
CN110548410A (en) * | 2018-06-04 | 2019-12-10 | 宁波蓝盾新材料科技有限公司 | Polypeptide modified graphene oxide modified composite antibacterial forward osmosis membrane and preparation method thereof |
US10640384B2 (en) | 2017-08-22 | 2020-05-05 | Ntherma Corporation | Graphene nanoribbons, graphene nanoplatelets and mixtures thereof and methods of synthesis |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
US11097227B2 (en) | 2019-05-15 | 2021-08-24 | Via Separations, Inc. | Durable graphene oxide membranes |
US11123694B2 (en) | 2019-05-15 | 2021-09-21 | Via Separations, Inc. | Filtration apparatus containing graphene oxide membrane |
WO2021229198A1 (en) * | 2020-05-14 | 2021-11-18 | Graphene Composites Limited | Viral active and/or anti-microbial inks and coatings |
US11208330B2 (en) | 2016-11-16 | 2021-12-28 | The Regents Of The University Of California | Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings |
US11465398B2 (en) | 2014-03-14 | 2022-10-11 | University Of Maryland, College Park | Layer-by-layer assembly of graphene oxide membranes via electrostatic interaction and eludication of water and solute transport mechanisms |
US11913692B2 (en) | 2021-11-29 | 2024-02-27 | Via Separations, Inc. | Heat exchanger integration with membrane system for evaporator pre-concentration |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2853670C (en) | 2011-10-27 | 2017-06-13 | Garmor, Inc. | Composite graphene structures |
US9108158B2 (en) * | 2013-02-14 | 2015-08-18 | University Of South Carolina | Ultrathin, molecular-sieving graphene oxide membranes for separations along with their methods of formation and use |
JP6134396B2 (en) | 2013-03-08 | 2017-05-24 | ガーマー インク.Garmor, Inc. | Graphene companion at the host |
US9266750B2 (en) * | 2013-08-23 | 2016-02-23 | Energysolutions, Inc. | Systems and methods for isotopic water separation |
US9475007B2 (en) | 2013-08-23 | 2016-10-25 | Energysolutions, Inc. | Methods relating to isotopic water filtration |
CN103706264B (en) * | 2014-01-14 | 2016-01-27 | 中国海洋大学 | LBL self-assembly graphene oxide NF membrane and preparation method thereof |
CN103785223B (en) * | 2014-02-14 | 2015-09-02 | 济宁利特纳米技术有限责任公司 | A kind of preparation method of graphene oxide water purification catridge |
US10017706B1 (en) | 2014-04-02 | 2018-07-10 | Precision Combustion, Inc. | Additive for combustion enhancement of liquid hydrocarbon fuels |
GB2521237B (en) | 2014-06-09 | 2015-11-11 | Filton Systems Engineering Ltd | Fuel tank valve assembly |
WO2016024506A1 (en) * | 2014-08-11 | 2016-02-18 | 国立大学法人信州大学 | Method for producing molded filter body |
KR20170113624A (en) * | 2015-02-06 | 2017-10-12 | 캐보트 코포레이션 | Element isolation composition and method |
GB2538543A (en) * | 2015-05-21 | 2016-11-23 | Airbus Operations Ltd | Cyclonic separator |
US11482348B2 (en) * | 2015-06-09 | 2022-10-25 | Asbury Graphite Of North Carolina, Inc. | Graphite oxide and polyacrylonitrile based composite |
WO2017023379A1 (en) * | 2015-08-06 | 2017-02-09 | Lockheed Martin Corporation | Implantable graphene membranes with low cytotoxicity |
WO2017053204A1 (en) | 2015-09-21 | 2017-03-30 | Garmor Inc. | Low-cost, high-performance composite bipolar plate |
CN105540869B (en) * | 2015-12-17 | 2018-04-03 | 苏州大学 | A kind of modified graphene oxide composite for loading Paracoccus denitrificans and its production and use |
CN105582751B (en) * | 2015-12-17 | 2018-05-22 | 常州碳星科技有限公司 | Filter core and its preparation method and application |
EP3281695A1 (en) | 2016-08-11 | 2018-02-14 | Freie Universität Berlin | Filtration device |
IT201600100786A1 (en) * | 2016-10-07 | 2018-04-07 | Pietro Fiorentini Spa | DEVICE AND METHOD FOR WATER PURIFICATION |
US11214658B2 (en) | 2016-10-26 | 2022-01-04 | Garmor Inc. | Additive coated particles for low cost high performance materials |
CN110114126A (en) * | 2016-10-26 | 2019-08-09 | 标准石墨烯有限公司 | Water purification filter comprising redox graphene layer and the water purification system comprising it |
WO2020041435A1 (en) | 2018-08-24 | 2020-02-27 | Tetrels Technology Corporation | Devices and methods for water-filtration membranes |
US11203721B1 (en) * | 2019-04-26 | 2021-12-21 | Precision Combustion, Inc. | Process of removing a metal from a fluid hydrocarbon |
US11015128B1 (en) * | 2019-04-26 | 2021-05-25 | Precision Combustion, Inc. | Process of removing a metal from a fluid hydrocarbon |
WO2021050576A1 (en) * | 2019-09-11 | 2021-03-18 | Ojai Energetics Pbc | Filtration devices and methods thereof |
US11791061B2 (en) | 2019-09-12 | 2023-10-17 | Asbury Graphite North Carolina, Inc. | Conductive high strength extrudable ultra high molecular weight polymer graphene oxide composite |
CN110467445A (en) * | 2019-09-24 | 2019-11-19 | 广州康滤净化科技有限公司 | A kind of graphene Ceramic Composite filter core and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3457171A (en) | 1967-02-13 | 1969-07-22 | Westinghouse Electric Corp | Graphitic oxide memberane for desalinating water |
US8501858B2 (en) | 2002-09-12 | 2013-08-06 | Board Of Trustees Of Michigan State University | Expanded graphite and products produced therefrom |
US8182917B2 (en) | 2008-03-20 | 2012-05-22 | The United States Of America, As Represented By The Secretary Of The Navy | Reduced graphene oxide film |
US9625062B2 (en) | 2008-04-07 | 2017-04-18 | John M. Crain | Fuel system components |
JP2013542053A (en) | 2010-09-03 | 2013-11-21 | インディアン インスティテュート オブ テクノロジー | Reduced graphene oxide based composite for water purification |
US8925736B2 (en) | 2011-09-12 | 2015-01-06 | University Of Houston | Nanocomposite polymer-carbon based nanomaterial filters for the simultaneous removal of bacteria and heavy metals |
CN102908908B (en) | 2012-11-12 | 2014-10-22 | 景德镇陶瓷学院 | Method for modifying modified ceramic microfiltration membrane by adopting graphite oxide |
-
2013
- 2013-07-12 US US13/940,612 patent/US9403112B2/en active Active
Non-Patent Citations (1)
Title |
---|
Handbook of solvents, Wypych, editor, William Andrew Publishing, Toronto-New Yor, 2001, page 68. * |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9833748B2 (en) | 2010-08-25 | 2017-12-05 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US10471199B2 (en) | 2013-06-21 | 2019-11-12 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
US10029215B2 (en) * | 2014-03-07 | 2018-07-24 | Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University) | Graphene oxide nanocomposite membrane for gas separation, reduced graphene oxide nanocomposite membrane and method for manufacturing the same |
US20170014778A1 (en) * | 2014-03-07 | 2017-01-19 | Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University) | Graphene oxide nanocomposite membrane for gas separation, reduced graphene oxide nanocomposite membrane, and method for manufacturing the same |
US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US11465398B2 (en) | 2014-03-14 | 2022-10-11 | University Of Maryland, College Park | Layer-by-layer assembly of graphene oxide membranes via electrostatic interaction and eludication of water and solute transport mechanisms |
EP3188823A4 (en) * | 2014-09-02 | 2018-04-25 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
US10005038B2 (en) | 2014-09-02 | 2018-06-26 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
WO2016036888A1 (en) * | 2014-09-02 | 2016-03-10 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
CN107073408A (en) * | 2014-09-02 | 2017-08-18 | 洛克希德马丁公司 | Hemodialysis membrane and blood filtering membrane and its application process based on two-dimentional membrane material |
CN104606802A (en) * | 2015-01-22 | 2015-05-13 | 东南大学 | Filter element and preparation method and application thereof |
US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
WO2017023380A1 (en) | 2015-08-05 | 2017-02-09 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
US10981120B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
US10974208B2 (en) | 2016-05-11 | 2021-04-13 | Massachusetts Institute Of Technology | Graphene oxide membranes and related methods |
WO2017197205A1 (en) * | 2016-05-11 | 2017-11-16 | Massachusetts Institute Of Technology | Graphene oxide membranes and related methods |
US11208330B2 (en) | 2016-11-16 | 2021-12-28 | The Regents Of The University Of California | Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings |
US11981571B2 (en) | 2016-11-16 | 2024-05-14 | The Regents Of The University Of California | Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings |
WO2018111252A1 (en) * | 2016-12-14 | 2018-06-21 | South Dakota Board Of Regents | Graphene containing coatings, production process thereof and use |
CN106830349A (en) * | 2016-12-28 | 2017-06-13 | 苏州大学 | Polymer-modified material of microorganism and preparation method thereof is wrapped up with the application in N, the treatment of N dimethylformamides |
US10640384B2 (en) | 2017-08-22 | 2020-05-05 | Ntherma Corporation | Graphene nanoribbons, graphene nanoplatelets and mixtures thereof and methods of synthesis |
WO2019096066A1 (en) * | 2017-11-14 | 2019-05-23 | 中国农业科学院油料作物研究所 | Aflatoxin-adsorbing filter cloth, preparation method and use thereof |
CN110548410A (en) * | 2018-06-04 | 2019-12-10 | 宁波蓝盾新材料科技有限公司 | Polypeptide modified graphene oxide modified composite antibacterial forward osmosis membrane and preparation method thereof |
US11097227B2 (en) | 2019-05-15 | 2021-08-24 | Via Separations, Inc. | Durable graphene oxide membranes |
US11123694B2 (en) | 2019-05-15 | 2021-09-21 | Via Separations, Inc. | Filtration apparatus containing graphene oxide membrane |
US11498034B2 (en) | 2019-05-15 | 2022-11-15 | Via Separations, Inc. | Durable graphene oxide membranes |
WO2021229198A1 (en) * | 2020-05-14 | 2021-11-18 | Graphene Composites Limited | Viral active and/or anti-microbial inks and coatings |
US11913692B2 (en) | 2021-11-29 | 2024-02-27 | Via Separations, Inc. | Heat exchanger integration with membrane system for evaporator pre-concentration |
Also Published As
Publication number | Publication date |
---|---|
US9403112B2 (en) | 2016-08-02 |
US20130330833A1 (en) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9403112B2 (en) | Graphene oxide filters and methods of use | |
Bhattacharya et al. | Development and performance evaluation of a novel CuO/TiO2 ceramic ultrafiltration membrane for ciprofloxacin removal | |
Zhao et al. | Highly antifouling and antibacterial performance of poly (vinylidene fluoride) ultrafiltration membranes blending with copper oxide and graphene oxide nanofillers for effective wastewater treatment | |
Meng et al. | Recent advances in membrane bioreactors (MBRs): membrane fouling and membrane material | |
Ghayeni et al. | Bacterial passage through microfiltration membranes in wastewater applications | |
Castaing et al. | Immersed hollow fibres microfiltration (MF) for removing undesirable micro-algae and protecting semi-closed aquaculture basins | |
US7815806B2 (en) | Purification of fluids with carbon nanotubes having attached functional group | |
Babel et al. | Chemical pretreatment for reduction of membrane fouling caused by algae | |
CN107267369B (en) | Microorganism concentration method and apparatus | |
Elcik et al. | The fouling effects of microalgal cells on crossflow membrane filtration | |
Jain et al. | The potential application of carbon nanotubes in water Treatment: A state-of-the-art-review | |
Kokilathasan et al. | Nanoplastics: detection and impacts in aquatic environments–a review | |
Ruiz et al. | Graphene oxide-based nanofilters efficiently remove bacteria from fuel | |
WO2013188521A1 (en) | Graphene oxide filters and methods of use | |
CN113144919A (en) | 3D printing multifunctional filter membrane for sewage treatment and preparation method and application thereof | |
Zhang et al. | Anti-fouling mechanism of ultrafiltration membranes modified by graphene oxide with different charged groups under simulated seawater conditions | |
Chong et al. | Nanohybrid membrane in algal-membrane photoreactor: Microalgae cultivation and wastewater polishing | |
Shiri et al. | The potential of microalgae Dunaliella salina to treat shrimp pond wastewater in a PAN/GO membrane bioreactor | |
Sun et al. | New insight in algal cell adhesion and cake layer evolution in algal-related membrane processes: Size-fractioned particles, initial foulant seeds and EDEM simulation | |
Solov’ev et al. | Track membrane with immobilized colloid silver particles | |
CN109576161B (en) | Chlorella W1 capable of removing heavy metals in water with high heavy metal content and application thereof | |
Tang et al. | Calcium-facilitated adsorption and precipitation of bacteria on the graphene oxide surface | |
EP1852176B1 (en) | Purification of fluids with nanomaterials | |
He et al. | Isoporous membrane from PS-b-PAA/MWCNT-Ag composite with high photothermal conversion efficiency | |
Gupta et al. | Zinc oxide nanoparticles decorated fluorescent and antibacterial glass fiber pre-filter paper |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RUIZ, OSCAR N.;BUNKER, CHRISTOPHER E.;REEL/FRAME:032492/0022 Effective date: 20120815 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: UNIVERSITY OF DAYTON, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FERNANDO, K.A. SHIRAL;REEL/FRAME:039035/0329 Effective date: 20140311 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |